MedTrace Logo

Glucose Tolerance in Children With Cystic Fibrosis

NCT02569229 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2022-11-21

No results posted yet for this study

Summary

The aim is to describe the association of glucose tolerance measured with three different tools (continuous glucose measurement system - CGMS, oral glucose tolerance testing - OGTT and optional intravenous glucose tolerance testing -IVGTT) with parameters out of lung function and anthropometric parameters in patients with cystic fibrosis.

Conditions

Interventions

OTHER

Diagnostics for glucose tolerance with 3 different methods.

1. A 7-day course of subcutaneous continuous glucose monitoring system (CGMS). 2. An oral glucose tolerance test done within the 7 day period of CGMS. 3. Optionally a intravenous glucose tolerance test done within the 7 day period of CGMS.

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    collaborator OTHER

  • Christoph Saner

    lead OTHER

Principal Investigators

  • Christoph Saner, MD · University childrens Hospital, UKBB, Basel Switzerland

  • Urs Zumsteg, Prof · University childrens Hospital, UKBB, Basel Switzerland

Eligibility

Min Age
10 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-11-18
Completion
2016-11-18

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02569229 on ClinicalTrials.gov